利用工程共生菌预防感染。
Engineering commensal bacteria for prophylaxis against infection.
机构信息
Department of Biological and Environmental Engineering, Cornell University, Ithaca, NY 14853, USA.
出版信息
Curr Opin Biotechnol. 2012 Dec;23(6):924-30. doi: 10.1016/j.copbio.2012.03.004. Epub 2012 Mar 28.
Abstract
Infectious diseases are the leading causes of death worldwide. The development of efficient and low cost prophylactics to prevent pathogenic infection is given high priority in the twenty-first century. Commensal bacteria are largely seen as harmless and can survive symbiotically (in many cases) in niches throughout the human body. Advances in genetic engineering and understanding of pathogenesis have revealed many potential strategies to develop engineered bacteria for prophylaxis purposes: including live vaccines and anti-infective agents. In this review, we discuss recent advances and potentialities of prophylaxis with engineered bacteria.
摘要
传染病是全球死亡的主要原因。在 21 世纪，开发高效、低成本的预防措施来预防病原感染被高度重视。共生菌在很大程度上被认为是无害的，并且可以在人体的许多部位共生（在许多情况下）。遗传工程学的进步和对发病机制的理解揭示了许多潜在的策略，可用于开发用于预防目的的工程细菌：包括活疫苗和抗感染剂。在这篇综述中，我们讨论了用工程细菌进行预防的最新进展和潜力。
相似文献
1
Engineering commensal bacteria for prophylaxis against infection.利用工程共生菌预防感染。
Curr Opin Biotechnol. 2012 Dec;23(6):924-30. doi: 10.1016/j.copbio.2012.03.004. Epub 2012 Mar 28.
2
Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology.探索工程化新城疫病毒在现代疫苗学中的前景。
Viruses. 2020 Apr 16;12(4):451. doi: 10.3390/v12040451.
3
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.使用活细菌疫苗载体进行抗原递送：潜力与局限
Vaccine. 2001 Feb 8;19(13-14):1573-80. doi: 10.1016/s0264-410x(00)00354-6.
4
Novel viral vectors in infectious diseases.传染病中的新型病毒载体
Immunology. 2018 Jan;153(1):1-9. doi: 10.1111/imm.12829. Epub 2017 Sep 26.
5
Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines.CRISPR-Cas9 编辑在病毒工程和重组病毒疫苗开发中的应用。
CRISPR J. 2021 Aug;4(4):477-490. doi: 10.1089/crispr.2021.0017.
6
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.工程共生菌作为抗感染黏膜保护剂的递送系统。
Biotechnol Genet Eng Rev. 2002;19:139-56. doi: 10.1080/02648725.2002.10648027.
7
Engineered bacteria as therapeutic agents.工程菌作为治疗剂。
Curr Opin Biotechnol. 2015 Dec;35:94-102. doi: 10.1016/j.copbio.2015.05.004. Epub 2015 Jun 9.
8
Viral Pathogenesis, Recombinant Vaccines, and Oncolytic Virotherapy: Applications of the Canine Distemper Virus Reverse Genetics System.病毒发病机制、重组疫苗和溶瘤病毒治疗：犬瘟热病毒反向遗传系统的应用。
Viruses. 2020 Mar 20;12(3):339. doi: 10.3390/v12030339.
9
A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR/Cas9 system.利用 CRISPR/Cas9 系统开发重组禽疱疹病毒载体疫苗的简单快速方法。
Vaccine. 2018 Jan 29;36(5):716-722. doi: 10.1016/j.vaccine.2017.12.025. Epub 2018 Jan 2.
10
Live bacterial delivery systems for development of mucosal vaccines.用于黏膜疫苗开发的活细菌递送系统。
Curr Opin Mol Ther. 2000 Feb;2(1):94-9.
引用本文的文献
1
Minimal logic gates for probiotic Nissle 1917 sensing and treatment of dual-bacteria intestinal infection.用于益生菌Nissle 1917感应和治疗双菌肠道感染的最小逻辑门。
Gut Microbes. 2025 Dec;17(1):2530156. doi: 10.1080/19490976.2025.2530156. Epub 2025 Jul 6.
2
Surface display of p75, a Lactobacillus rhamnosus GG derived protein, on Bacillus subtilis spores and its antibacterial activity against Listeria monocytogenes.鼠李糖乳杆菌GG源蛋白p75在枯草芽孢杆菌孢子表面的展示及其对单核细胞增生李斯特菌的抗菌活性。
AMB Express. 2020 Aug 8;10(1):139. doi: 10.1186/s13568-020-01073-9.
3
A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease.一种作为治疗药物局部递送载体的基因工程细菌平台：迈向克罗恩病的应用
Bioeng Transl Med. 2018 Sep 23;3(3):209-221. doi: 10.1002/btm2.10113. eCollection 2018 Sep.
4
Quantitative and synthetic biology approaches to combat bacterial pathogens.对抗细菌病原体的定量生物学和合成生物学方法。
Curr Opin Biomed Eng. 2017 Dec;4:116-126. doi: 10.1016/j.cobme.2017.10.007. Epub 2017 Oct 24.
5
Development of Cell-Based Sentinels for Nitric Oxide: Ensuring Marker Expression and Unimodality.基于细胞的一氧化氮哨兵的开发：确保标记物表达和单峰性。
ACS Synth Biol. 2018 Jul 20;7(7):1694-1701. doi: 10.1021/acssynbio.8b00146. Epub 2018 Jul 9.
6
Designer cells programming quorum-sensing interference with microbes.设计细胞对微生物群体感应进行编程干扰。
Nat Commun. 2018 May 8;9(1):1822. doi: 10.1038/s41467-018-04223-7.
7
Sustainable therapies by engineered bacteria.工程菌的可持续疗法。
Microb Biotechnol. 2017 Sep;10(5):1057-1061. doi: 10.1111/1751-7915.12778. Epub 2017 Jul 11.
8
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models.工程益生菌大肠杆菌可消除和预防动物模型中的铜绿假单胞菌肠道感染。
Nat Commun. 2017 Apr 11;8:15028. doi: 10.1038/ncomms15028.
9
Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy.靶向宿主细胞器的病原菌：一种复杂的颠覆策略。
Nat Rev Microbiol. 2016 Jan;14(1):5-19. doi: 10.1038/nrmicro.2015.1. Epub 2015 Nov 23.
10
Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes.工程共生细菌将肠道细胞重编程为葡萄糖反应性胰岛素分泌细胞以治疗糖尿病。
Diabetes. 2015 May;64(5):1794-803. doi: 10.2337/db14-0635. Epub 2015 Jan 27.
本文引用的文献
1
Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro.表达李斯特菌黏附蛋白的重组益生菌可减弱李斯特菌毒力体外实验。
PLoS One. 2012;7(1):e29277. doi: 10.1371/journal.pone.0029277. Epub 2012 Jan 3.
2
Experimental and analytical tools for studying the human microbiome.研究人类微生物组的实验和分析工具。
Nat Rev Genet. 2011 Dec 16;13(1):47-58. doi: 10.1038/nrg3129.
3
A new approach to an old problem: synthetic biology tools for human disease and metabolism.解决老问题的新方法：用于人类疾病和新陈代谢的合成生物学工具。
Cold Spring Harb Symp Quant Biol. 2011;76:145-54. doi: 10.1101/sqb.2011.76.010686. Epub 2011 Dec 14.
4
Mucosal vaccination and therapy with genetically modified lactic acid bacteria.黏膜免疫接种和基因修饰乳酸杆菌治疗。
Annu Rev Food Sci Technol. 2011;2:423-45. doi: 10.1146/annurev-food-022510-133640.
5
Emerging biomedical applications of synthetic biology.合成生物学的新兴生物医学应用。
Nat Rev Genet. 2011 Nov 29;13(1):21-35. doi: 10.1038/nrg3094.
6
The Human Microbiome Project in 2011 and beyond.2011 年及以后的人类微生物组计划。
Cell Host Microbe. 2011 Oct 20;10(4):287-91. doi: 10.1016/j.chom.2011.10.001.
7
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.乳球菌和乳杆菌作为黏膜传递载体的治疗性蛋白质和 DNA 疫苗。
Microb Cell Fact. 2011 Aug 30;10 Suppl 1(Suppl 1):S4. doi: 10.1186/1475-2859-10-S1-S4.
8
Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus.利用新月柄杆菌 S 层展示的抗体增强对 HIV 的中和作用。
Antimicrob Agents Chemother. 2011 Dec;55(12):5547-52. doi: 10.1128/AAC.00509-11. Epub 2011 Sep 6.
9
Synthetic biology moving into the clinic.合成生物学进入临床应用。
Science. 2011 Sep 2;333(6047):1248-52. doi: 10.1126/science.1206843.
10
Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen.利用工程微生物来感知和消除人类病原体铜绿假单胞菌。
Mol Syst Biol. 2011 Aug 16;7:521. doi: 10.1038/msb.2011.55.
Zotero 插件